Astrazeneca Plc Adr Stock Price on March 25, 2024
AZN Stock | USD 75.17 0.14 0.19% |
If you're considering investing in AstraZeneca Stock, it is important to understand the factors that can impact its price. As of today, the current price of AstraZeneca PLC stands at 75.17, as last reported on the 28th of April, with the highest price reaching 75.49 and the lowest price hitting 74.59 during the day. AstraZeneca PLC appears to be very steady, given 3 months investment horizon. AstraZeneca PLC ADR secures Sharpe Ratio (or Efficiency) of 0.15, which signifies that the company had a 0.15% return per unit of risk over the last 3 months. We have found thirty technical indicators for AstraZeneca PLC ADR, which you can use to evaluate the volatility of the firm. Please makes use of AstraZeneca PLC's Mean Deviation of 0.9698, risk adjusted performance of 0.0982, and Downside Deviation of 1.34 to double-check if our risk estimates are consistent with your expectations.
AstraZeneca Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
AstraZeneca |
Sharpe Ratio = 0.1484
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | AZN | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.41 actual daily | 12 88% of assets are more volatile |
Expected Return
0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average AstraZeneca PLC is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AstraZeneca PLC by adding it to a well-diversified portfolio.
AstraZeneca PLC Main Headline on 25th of March 2024
AstraZeneca PLC ADR dividend paid on 25th of March 2024 |
AstraZeneca PLC Valuation on March 25, 2024
It is possible to determine the worth of AstraZeneca PLC on a given historical date. On March 25, 2024 AstraZeneca was worth 66.21 at the beginning of the trading date compared to the closed value of 65.86. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of AstraZeneca PLC stock. Still, in general, we apply an absolute valuation method to find AstraZeneca PLC's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of AstraZeneca PLC where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against AstraZeneca PLC's related companies.
Open | High | Low | Close | Volume | |
66.49 | 66.84 | 66.20 | 66.26 | 4,098,644 | |
03/25/2024 | 66.21 | 66.43 | 65.80 | 65.86 | 4,424,629 |
66.25 | 66.46 | 65.77 | 66.33 | 3,133,174 |
Backtest AstraZeneca PLC | | | AstraZeneca PLC History | | | AstraZeneca PLC Valuation | Previous | Next |
AstraZeneca PLC Trading Date Momentum on March 25, 2024
On March 26 2024 AstraZeneca PLC ADR was traded for 66.33 at the closing time. Highest AstraZeneca PLC's price during the trading hours was 66.46 and the lowest price during the day was 65.77 . The net volume was 3.1 M. The overall trading history on the 26th of March contributed to the next trading period price boost. The overall trading delta to the next next day price was 0.71% . The overall trading delta to current price is 4.75% . |
AstraZeneca PLC ADR Fundamentals Correlations and Trends
By evaluating AstraZeneca PLC's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among AstraZeneca PLC's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. AstraZeneca financial account trend analysis is a perfect complement when working with valuation or volatility modules.About AstraZeneca PLC Stock history
AstraZeneca PLC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for AstraZeneca is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in AstraZeneca PLC ADR will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing AstraZeneca PLC stock prices may prove useful in developing a viable investing in AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. Astrazeneca Plc operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 83100 people.
AstraZeneca PLC Stock Technical Analysis
AstraZeneca PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
AstraZeneca PLC Period Price Range
Low | March 25, 2024
| High |
66.21 | 65.86 |
AstraZeneca PLC April 28, 2024 Market Strength
Market strength indicators help investors to evaluate how AstraZeneca PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AstraZeneca PLC shares will generate the highest return on investment. By undertsting and applying AstraZeneca PLC stock market strength indicators, traders can identify AstraZeneca PLC ADR entry and exit signals to maximize returns
Accumulation Distribution | 41961.71 | |||
Daily Balance Of Power | (0.56) | |||
Rate Of Daily Change | 0.99 | |||
Day Median Price | 66.12 | |||
Day Typical Price | 66.03 | |||
Price Action Indicator | (0.43) | |||
Period Momentum Indicator | 9.31 | |||
Relative Strength Index | 71.73 |
AstraZeneca PLC Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for AstraZeneca PLC's price direction in advance. Along with the technical and fundamental analysis of AstraZeneca Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of AstraZeneca to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0982 | |||
Jensen Alpha | 0.2042 | |||
Total Risk Alpha | 0.0203 | |||
Sortino Ratio | 0.0896 | |||
Treynor Ratio | (3.13) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for AstraZeneca Stock analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is AstraZeneca PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.